Author:
Coppin Chris,Porzsolt Franz,Autenrieth Michael,Kumpf Julia,Coldman Andrew,Wilt Timothy
Reference220 articles.
1. Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: the European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951);Aass;Journal of Clinical Oncology,2005
2. Interferon-a-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma: results of a randomized phase II study (EORTC 30951);Fossa;Cancer,2004
3. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects;Adler;Journal of Biological Response Modifiers,1987
4. SC-interleukin-2 and sc-interferon-alpha therapy in combination with iv-5-fluorouracil in metastatic renal cell carcinoma;Anton,1996
5. A randomized clinical trial comparing sc interleukin-2, sc alpha-2a-interferon, and iv bolus 5-flurouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients;Atzpodien,1997
Cited by
428 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献